Close
Apr 25, 2024 04:41PM
Apr 25, 2024 04:25PM
Apr 25, 2024 04:20PM
Apr 25, 2024 04:07PM
Apr 25, 2024 09:29AM
Apr 25, 2024 08:32AM
Apr 25, 2024 08:29AM AbbVie (ABBV): New Data Show RINVOQ Demonstrated Superiority Versus DUPIXENT Across Primary and All Secondary Endpoints
Apr 25, 2024 07:30AM
Apr 25, 2024 07:03AM
Apr 25, 2024 07:01AM
Apr 25, 2024 06:55AM
Apr 25, 2024 05:55AM
Apr 24, 2024 04:01PM
Apr 24, 2024 09:25AM Gain Therapeutics (GANX) Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287
Apr 24, 2024 09:00AM
Apr 24, 2024 08:47AM
Apr 24, 2024 08:30AM
Apr 24, 2024 08:09AM
Apr 24, 2024 08:01AM
Apr 24, 2024 08:00AM
Apr 24, 2024 07:31AM Arrowhead Pharmaceuticals Inc. (ARWR) Initiates Phase 1/2a Study of ARO-CFB
Apr 24, 2024 07:05AM
Apr 24, 2024 07:02AM
Apr 24, 2024 07:01AM
Apr 24, 2024 07:01AM
Apr 24, 2024 06:16AM
Apr 24, 2024 05:51AM
Apr 23, 2024 03:57PM Day One Biopharmaceuticals' (DAWN) OJEMDA Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
Apr 23, 2024 02:12PM
Apr 23, 2024 01:58PM
Apr 23, 2024 09:19AM
Apr 23, 2024 08:32AM
Apr 23, 2024 08:31AM
Apr 23, 2024 08:05AM
Apr 23, 2024 08:02AM Edgewise Therapeutics Inc. (EWTX) Granted EU Orphan Drug Designations for Sevasemten
Apr 23, 2024 08:02AM
Apr 23, 2024 08:01AM
Apr 23, 2024 08:00AM
Apr 23, 2024 07:33AM
Apr 23, 2024 07:03AM
Apr 23, 2024 07:01AM
Apr 23, 2024 07:01AM Neurocrine Biosciences (NBIX) Reports Positive Phase 2 Data for NBI-1065845
Apr 23, 2024 06:15AM
Apr 23, 2024 06:00AM
Apr 22, 2024 10:01PM
Apr 22, 2024 04:31PM
Apr 22, 2024 04:31PM
Apr 22, 2024 04:05PM
Apr 22, 2024 01:07PM Legend Biotech (LEGN) Reports CARVYKTI Approved in EU
Apr 22, 2024 09:04AM

66,892 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving FDA reports.